Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease

Liberatore, Gabriel T., Jackson-Lewis, Vernice, Vukosavic, Slobodanka, Mandir, Allen S., Vila, Miquel, McAuliffe, W. Geoffrey, Dawson, Valina L., Dawson, Ted M. +1 more·1999·Nature Medicine

Cited by (1,000)

Items 801–900 of 1,000

  1. Norfluoxetine Prevents Degeneration of Dopamine Neurons by Inhibiting Microglia-Derived Oxidative Stress in an MPTP Mouse Model of Parkinson’s Disease
    Kyung-In Kim, Young Cheul Chung, Byung Kwan Jin · 2018 · Mediators of Inflammation
  2. The Protein-Rich Fraction from Spirulina platensis Exerts Neuroprotection in Hemiparkinsonian Rats by Decreasing Brain Inflammatory-Related Enzymes and Glial Fibrillary Acidic Protein Expressions
    Maria Janice Pereira Lopes, Gyllyandeson de Araújo Delmondes, Giovana Mendes de Lacerda, Débora Rejane Alves Cavalcante, Pedro Éverson Alexandre de Aquino, Francisco Arnaldo Viana Lima, Kelly Rose Tavares Neves, Andréa Santos Costa, Hermógenes David de Oliveira, Cícero Francisco Bezerra Felipe et al. · 2022 · Journal of Medicinal Food
  3. Deficiency of miR-29a/b1 leads to premature aging and dopaminergic neuroprotection in mice
    Xiaochen Bai, Jinghui Wang, Xiaoshuang Zhang, Yilin Tang, Yongtao He, Jiayin Zhao, Linlin Han, Rong Fang, Zhaolin Liu, Hongtian Dong et al. · 2022 · Frontiers in Molecular Neuroscience
  4. [18F]NOS PET Brain Imaging Suggests Elevated Neuroinflammation in Idiopathic Parkinson’s Disease
    Robert K. Doot, Anthony J. Young, Ilya M. Nasrallah, Reagan R. Wetherill, Andrew D. Siderowf, Robert H. Mach, Jacob G. Dubroff · 2022 · Cells
  5. Antioxidant properties of PF9601N, a novel MAO-B inhibitor: assessment of its ability to interact with reactive nitrogen species.
    Lydia Bellik, Stefania Dragoni, Federica Pessina, Elisenda Sanz, Mercedes Unzeta, Massimo Valoti · 2010 · Acta Biochimica Polonica
  6. A new route for the integration of a graphene/diazonium/PEDOT electrode towards antioxidant biomarker detection
    Loïc Assaud, Nicolas Massonnet, David Evrard, Hugues Vergnes, Ludovic Salvagnac, Véronique Conédéra, Laure Noé, Marc Monthioux, Pierre Gros, Pierre Temple‐Boyer et al. · 2016 · Journal of Electroanalytical Chemistry
  7. Potential neuroprotective effect of low dose whole-body γ-irradiation against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic toxicity in C57 mice
    Yajie Liang, Shurong Li, Qiang Zou, Bingyin Su · 2006 · Neuroscience Letters
  8. Microglial activation is not prevented by tacrolimus but dopamine neuron damage is reduced in a rat model of Parkinson's disease progression
    Ann K. Wright, Clare E. Miller, Maya Williams, Gordon William Arbuthnott · 2008 · Brain Research
  9. Cochlear ablation in mice lacking SHP-1 results in an extended period of cell death of anteroventral cochlear nucleus neurons
    Jie Zhao, Diana I. Lurie · 2004 · Hearing Research
  10. Molecular neurotoxicological models of Parkinsonism: focus on genetic manipulation of mice
    Jean Lud Cadet · 2001 · Parkinsonism & Related Disorders
  11. Cypermethrin Induces the Activation of Rat Primary Microglia and Expression of Inflammatory Proteins
    Saumya Mishra, Charul Rajput, Mahendra Pratap Singh · 2020 · Journal of Molecular Neuroscience
  12. A bibenzyl compound 20C protects rats against 6-OHDA-induced damage by regulating adaptive immunity associated molecules
    Shuo Wang, Qi-wen Han, Tian-Tian Zhou, Chenglu Zhang, Chenggen Zhu, Zhou Xin, Nai‐Hong Chen, Yu‐He Yuan, Jian‐Gong Shi · 2020 · International Immunopharmacology
  13. BL-1023 improves behavior and neuronal survival in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-intoxicated mice
    Jessica A.L. Hutter-Saunders, Lisa M. Kosloski, JoEllyn McMillan, N. Yotam, T. Rinat, Rodney Lee Mosley, Howard Eliot Gendelman · 2011 · Neuroscience
  14. Neuroprotective Effect of Optimized Yinxieling Formula in 6-OHDA-Induced Chronic Model of Parkinson’s Disease through the Inflammation Pathway
    Renrong Wei, Cuiping Rong, Qingfeng Xie, Shouhai Wu, Yuchao Feng, Ruihua Wang, Zhenhui Dai, Tongxiang Lin · 2019 · Evidence-based Complementary and Alternative Medicine
  15. NO-induced apoptosis and ER stress in microglia
    Kohichi Kawahara, Masataka Mori, Hitoshi Nakayama · 2004 · Folia Pharmacologica Japonica
  16. Dietary Restriction Does Not Protect the Nigrostriatal Dopaminergic Pathway of Older Animals From Low-Dose MPTP-Induced Neurotoxicity
    WILLIAM W. MORGAN, Arlan G Richardson, James F. Nelson · 2003 · The Journals of Gerontology Series A
  17. Characterization of neurotransmitters and dopamine attenuation of inducible nitric oxide synthase in glioma cells
    ELIZABETH A. MAZZIO, Alan Becker, Karam F. A. Soliman · 2002 · Journal of Neuroimmunology
  18. Pathologic and Immunohistochemical Findings in Hypothalamic and Mesencephalic Regions in the Pahenu2 Mouse Model for Phenylketonuria
    Jennifer E. Embury, Roger L. Reep, Philip J. Laipis · 2005 · Pediatric Research
  19. Endogenous GDNF Is Unable to Halt Dopaminergic Injury Triggered by Microglial Activation
    Julieta Mendes‐Oliveira, Filipa Lopes Campos, Susana Alves Ferreira, Diogo Tomé, Carla P. Fonseca, Graça Baltazar · 2023 · Cells
  20. Cortistatin as a Novel Multimodal Therapy for the Treatment of Parkinson’s Disease
    Ignacio Serrano-Martínez, Marta Pedreño, Julia Castillo-González, V. Ferraz-de-Paula, Pablo Vargas-Rodríguez, Irene Forte‐Lago, Marta Caro, Jenny Campos‐Salinas, Javier Villadiego, Pablo Peñalver et al. · 2024 · International Journal of Molecular Sciences
  21. Nitric Oxide Involvement in Cardiovascular Dysfunctions of Parkinson Disease
    Marli Cardoso Martins‐Pinge, Lorena de Jager, Blenda Hyedra de Campos, Lorena Oliveira Bezerra, Pamela Giovana Turini, Phileno Pinge‐Filho · 2022 · Frontiers in Pharmacology
  22. Gdf-15 deficiency does not alter vulnerability of nigrostriatal dopaminergic system in MPTP-intoxicated mice
    Venissa Machado, Ralf Gilsbach, Richa Das, Andreas Schober, Lioudmila Bogatyreva, Dieter Hauschke, Kerstin G. KRIEGLSTEIN, Klaus Unsicker, Björn Spittau · 2016 · Cell and Tissue Research
  23. Potential repositioning of exemestane as a neuroprotective agent for Parkinson’s disease
    Hyo Jin Son, Se Hee Han, Ji Ae Lee, Eun Jung Shin, Onyou Hwang · 2017 · Free Radical Research
  24. Morphinan Neuroprotection: New Insight into the Therapy of Neurodegeneration
    Wei Zhang, Jau‐Shyong Hong, Hyoung‐Chun Kim, Wanqin Zhang, Michelle L. Block · 2004 · Critical Reviews in Neurobiology
  25. iTRAQ-based proteomic analysis of tetramethylpyrazine inhibition on lipopolysaccharide-induced microglial activation
    Qiang-Hong Pu, Junlin He, Mingjun Wu, Jiajia Li, Yang Zhu, Yingxiong Wang, Chao Yu · 2014 · Life Sciences
  26. Permanently compromised NADPH-diaphorase activity within the osmotically activated supraoptic nucleus after in utero but not adult exposure to Aroclor 1254
    Cary G. Coburn, Abena Watson-Siriboe, Borin Hou, Chad C. Cheetham, Elizabeth R. Gillard, Lisa D. Lin, Martha León‐Olea, Eduardo Sánchez-Islas, Samuel Mucio-Ramírez, Margarita Currás‐Collazo · 2015 · NeuroToxicology
  27. Dynamic alterations of gene expression of nicotinic acetylcholine receptor α7, α4 and β2 subunits in an acute MPTP-lesioned mouse model
    Jun Hu, Chenlei Zhu, Yuan Liu, Fang Wang, Zuhu Huang, Weimin Fan, Jie Wu · 2011 · Neuroscience Letters
  28. Activated Microglia Persist in the Substantia Nigra of a Chronic MPTP Mouse Model of Parkinson’s Disease
    Gloria E. Meredith, Adrian G. Dervan, Susan Totterdell · 2006 · Kluwer Academic Publishers eBooks
  29. Toxic animal models
    Serge Przedborski, Kim Tieu · 2005 · Cambridge University Press eBooks
  30. Chaperone nanomotors with chemotactic ability for the treatment of Parkinson’s disease
    Wenjing Wang, Xue Xia, Ziqiang Zhang, Qingya Zhu, Yu Chen, Yao Zhang, Lin Chen, Chun Mao, Mimi Wan · 2025 · Science Advances
  31. Reversal effect of simvastatin on the decrease in cannabinoid receptor 1 density in 6-hydroxydopamine lesioned rat brains
    Nikolce Mackovski, Jinchi Liao, Ruihui Weng, Xiaobo Wei, Rui Wang, Zhaoyu Chen, Xu Liu, Yinghua Yu, Barbara J. Meyer, Ying Xia et al. · 2016 · Life Sciences
  32. Etiology and Pathogenesis of Parkinson’s Disease
    Briana R. De Miranda, J. Timothy Greenamyre · 2017 · Royal Society of Chemistry eBooks
  33. Peripheral Delivery of Neural Precursor Cells Ameliorates Parkinson’s Disease-Associated Pathology
    George A. Edwards, Nazaret Gamez, Enrique Armijo, Carlos Kramm, Rodrigo Morales, Kathleen Taylor-Presse, Paul Ernest Schulz, Claudio A. Soto, Inés Moreno‐González · 2019 · Cells
  34. Inhibition of inducible nitric oxide synthase and interleukin-1β expression by tunicamycin in cultured glial cells exposed to lipopolysaccharide
    Toru Hosoi, Jun Noguchi, Misae Takakuwa, Miya Honda, Yasunobu Okuma, Yasuyuki Nomura, Koichiro Ozawa · 2014 · Brain Research
  35. 1‐Methyl‐4‐phenylpyridinium ion, a toxin that can cause parkinsonism, alters branched structures of DNA
    Mitsutoshi Iwaasa, Shuyo Umeda, Takashi Ohsato, Chihiro Takamatsu, Atushi Fukuoh, Hiroshi Iwasaki, Hideo Shinagawa, Naotaka Hamasaki, Dongchon Kang · 2002 · Journal of Neurochemistry
  36. “Good” and “Bad” Microglia in Parkinson’s Disease: An Understanding of Homeostatic Mechanisms in Immunomodulation
    Yu Tang, Weidong Le · 2014 · Springer eBooks
  37. Mouse Models of α-Synucleinopathy and Lewy Pathology
    Samuel Barbieri, Katja Hofele, Karl‐Heinz Wiederhold, A. Probst, Claudia Mistl, Simone Danner, Sabine Kauffmann, Bernd Sommer, Willibrordus Spooren, Markus Tolnay et al. · 2001 · Advances in experimental medicine and biology
  38. Studying Nitrosative Stress in Parkinson’s Disease
    Kenny K. K. Chung · 2015 · Methods in molecular biology
  39. Beneficial role of capsaicin through modulation of mitochondrial functions in MPTP-injected mice
    Sakshi Tyagi, Ajit Kumar Thakur · 2024 · Neuroscience and Behavioral Physiology
  40. Extract from Nasco pomace loaded in nutriosomes exerts anti-inflammatory effects in the MPTP mouse model of Parkinson's disease
    Pathik Parekh, Marcello Serra, Mohamad Allaw, Matteo Perra, Annalisa Pinna, Maria Manconi, Micaela Morelli · 2024 · Experimental Neurology
  41. Neuroprotective effect of asymmetric dimethylarginine against 1‐methyl‐4‐phenylpyridinium ion‐induced damage in PC12 cells
    Xiao‐Qing Tang, Yujuan Li, Jing Zhao, Xintian Shen, Chuntao Yang, Lili Fan, Bi Hu, Yuan‐Jian Li, Liao Duan-fan · 2010 · Clinical and Experimental Pharmacology and Physiology
  42. Morphine reverses the effects of 1-methyl-4-phenylpyridinium in PC12 cells through activating PI3K/Akt
    Yuan Fan, Yan Jing Chen, Se Zhang, Mengbing Huang, Shengdong Wang, Ye Li, Jie Bai · 2018 · International Journal of Neuroscience
  43. Neuroprotective effect of neferine, an alkaloid against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced Parkinson's disease mouse model
    Shendong Jing, Zhenhai Wang, Jun Zhang, Xianfeng Li, Ruifei Huang · 2021 · Pharmacognosy Magazine
  44. Neuronal or inducible nitric oxide synthase (NOS) expression level is not involved in the different susceptibility to nigro-striatal dopaminergic neurotoxicity induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) between C57BL/6 and BALB/c mice
    Tsuyoshi Ito, Kazuyuki Uchida, Hiroyuki Nakayama · 2011 · Experimental and Toxicologic Pathology
  45. In VivoEvidence of Increased nNOS Activity in Acute MPTP Neurotoxicity: A Functional Pharmacological MRI Study
    Tiing Yee Siow, Chiao-Chi V. Chen, Nina Wan, Kai-Ping N. Chow, Chen Chang · 2013 · BioMed Research International
  46. Mitochondria and Parkinson's Disease
    David K. Simon, Charleen T. Chu, Russell Howard Swerdlow · 2011 · Parkinson s Disease
  47. Adaptative responses of spinal astrocytes to oxidative stress
    Patricia Cassina, Hugo Peluffo, Luis Barbeito · 2001 · Progress in brain research
  48. Parkinson's disease
    L.V. Prasad Korlipara, Anthony H.V. Schapira · 2002 · International review of neurobiology
  49. Neurotoxic Actions and Mechanisms of Nitric Oxide
    Mirella Gonzalez‐Zulueta, Valina Lynn Dawson, Ted M. Dawson · 2000 · Elsevier eBooks
  50. Role for peroxisome proliferator-activated receptor-gamma in Alzheimer's disease.
    van Geel · 2001 · Open Repository and Bibliography (University of Luxembourg)
  51. The role of gasotransmitters in Parkinson's disease: Interplay of nitric oxide, carbon monoxide, and hydrogen sulfide
    Jennifer L. O'Connor, Dionisia M. Fountos, Bita Firouzan, Fateme Azizi, Rasoul Ghasemi, Khosrow Kashfi · 2025 · Neurotherapeutics
  52. Role of Nitric Oxide Modulators in Neuroprotective Effects of Mangiferin in 6-Hydroxydopamine-induced Parkinson’s Disease in Rats
    Prafulla Chandra Tiwari, Manju Jyoti Chaudhary, Rishi Pal, Rajendra Nath · 2023 · Annals of Neurosciences
  53. Neuroglia in neurodegeneration: Alzheimer, Parkinson, and Huntington disease
    Dmitry Lim, Carlos Matute, Fabio Cavaliere, Alexei Verkhratsky · 2025 · Handbook of clinical neurology
  54. Pentose-phosphate pathway disruption in the pathogenesis of Parkinson’s disease
    Laura Dunn, Vanessa Fairfield, Shanay Daham, Juan Pedro Bolaños, Simon Heales · 2014 · Translational Neuroscience
  55. Comparative Pharmacophore Modeling and QSAR Studies for Structural Requirements of some Substituted 2-Aminopyridine Derivatives as Inhibitors of Nitric Oxide Synthases
    Mukesh Chandra Sharma · 2015 · Interdisciplinary Sciences Computational Life Sciences
  56. Nitro Capsaicin Suppressed Microglial Activation and TNF-α-Induced Brain Microvascular Endothelial Cell Damage
    Sopana Jamornwan, Tanida Chokpanuwat, Kwanchanok Uppakara, Thanet Laorob, Uthai Wichai, Pimonrat Ketsawatsomkron, Witchuda Saengsawang · 2022 · Biomedicines
  57. Dangguijakyak-San Protects against 1-Methyl-4-phenyl-1,2,3,6,-tetrahydropyridine-Induced Neuronal Damage via Anti-Inflammatory Action
    Deok‐Sang Hwang, Hyo Geun Kim, Jun‐Bock Jang, Myung Sook Oh · 2013 · Evidence-based Complementary and Alternative Medicine
  58. Endurance Exercise Training Attenuates the up Regulation of iNOS in the Skeletal Muscles of Chronic/Progressive Mouse Model of Parkinson’s Disease
    Nour S. Erekat, Ahed J Al Khatib, Muhammed D. Al-Jarrah · 2013 · Journal of Neurology Research
  59. Neuroprotective effect of benzylideneacetophenone derivative on the MPTP model of neurodegeneration in mice
    Jun Mo Kang, Jae‐Chul Jung, Heejeong Kim, Heena Lim, Soyong Jang, Seikwan Oh · 2008 · Archives of Pharmacal Research
  60. Immune Responses in Neurodegenerative Diseases
    Rajeev Shrestha, Shakya Shrestha, Owain Richard Millington, James M. Brewer, Trevor John Bushell · 2015 · Kathmandu University Medical Journal
  61. Neurotoxins and Drugs for the Treatment of Parkinson's Disease. Part I: Neurotoxins, Levodopa, and Agents Influencing Dopamine Metabolism (A Review)
    M. Г. Кадиева, Оганесян Эдуард Тоникович, С. Х. Муцуева · 2005 · Pharmaceutical Chemistry Journal
  62. Association between Parkinson's disease and polymorphisms in the nNOS and iNOS genes in a community-based case-control study
    Clotilde Lévecque · 2002 · Human Molecular Genetics
  63. Inflammation and Parkinson’s Disease
    Miquel Vila · 2010 · Elsevier eBooks
  64. Neuroinflammation During Parkinson’s Disease: Key Cells and Molecules Involved in It
    Priyobrata Sinha, Nabanita Ghosh, S. Mitra, A. Bhattacharyya · 2016 · Springer eBooks
  65. Epigenetic Study of Parkinson's Disease in Experimental Animal Model
    Ehab Tousson, Afrah F. Salama, Wafaa Ibrahim, Saber A. Sakr, Ahmed Masoud, Mohamed Ahmed Akela, Mahmoud A. Abd El-Rahman · 2015 · Pharmacologia
  66. Nitrooxidative Stress and Neurodegeneration
    Michał Fiedorowicz, Paweł Grieb · 2012 · InTech eBooks
  67. Astrocyte-microglia interaction in the expression of a pro-inflammatory or pain-related phenotype: molecular and cellular aspects
    Massimo Barbierato · 2012 · Padua Research Archive (University of Padova)
  68. Relationship Between the Anxious Symptoms and the Neurotransmitter in Parkinson's Mice with Different Dosages of MPTP
    Yu Xia, Suzhen Ye, Jian Shi, Hanjin Huang · 2018 · Brazilian Archives of Biology and Technology
  69. The C-terminal domain of the heavy chain of tetanus toxin prevents the oxidative and nitrosative stress induced by acute toxicity of 1-methyl-4-phenylpyridinium, a rat model of Parkinson’s disease
    Felipe Patricio, Daniel Juárez-Torres, Aleidy Patricio-Martínez, Liliana Mendieta, Francisca Pérez‐Severiano, Sergio Montes, José Aguilera, Ilhuicamina Daniel Limón · 2021 · Neuroscience Research
  70. Neuroprotection of Dopaminergic Neurons by Hominis Placenta Herbal Acupuncture in in vitro and in vivo Models of Parkinson’s Disease Induced by MPP+/MPTP Toxicity
    Hyung Joon Jun, Sang‐Soo Nam, Young Suk Kim · 2015 · 대한침구학회지
  71. Glial Reaction in Parkinsons Diseases: Inflammatory Activation Signaling of Glia as a Potential Therapeutic Target
    Dong‐Kug Choi, Kyoungho Suk · 2007 · Current Signal Transduction Therapy
  72. The Parkinsonian neurotoxin 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine on membrane currents and intrasynaptosomal calcium
    Kochupurackal P. Mohanakumar, S Samanta Ray, Dietrich Büsselberg · 2002 · Neuroscience Research Communications
  73. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Mammalian Models of Parkinson's Disease
    Jay S. Schneider, David W. Anderson, Emmanuel Decamp · 2008 · Elsevier eBooks
  74. Aberrant Nitric Oxide Signaling Contributes to Protein Misfolding in Neurodegenerative Diseases via S-Nitrosylation and Tyrosine Nitration
    Tomohiro Nakamura, Stuart A. Lipton · 2017 · Elsevier eBooks
  75. From Man to Mouse: The MPTP Model of Parkinson Disease
    Vernice R. Jackson-Lewis, Richard Jay Smeyne · 2005 · Elsevier eBooks
  76. The role of inflammation in neurodegenerative diseases
    Stanley H. Appel, David R. Beers, Weihua Zhao · 2022 · Elsevier eBooks
  77. From Man to Mouse
    Vernic Jackson-Lewis, Deranda B. Lester, Elena A. Kozina, Serge Przedborski, Richard Jay Smeyne · 2014 · Elsevier eBooks
  78. Interactions among nitric oxide and Bcl‐family proteins after MPP+ exposure of SH‐SY5Y neural cells II: Exogenous NO replicates MPP+ actions
    Jameel Dennis, James P. Bennett · 2003 · Journal of Neuroscience Research
  79. Current concepts on the etiology and pathogenesis of Parkinson disease
    Stanley Fahn, Joseph J. Jankovic, Mark Hallett · 2011 · Elsevier eBooks
  80. Homocysteine and Parkinson’s Disease: A Complex Relationship
    Gayle Helane Doherty · 2013 · Journal of Neurological Disorders
  81. The Association of Enlarged Perivascular Space with Cerebrospinal Fluid GFAP in Early Parkinson’s Disease
    Qiuyue Li, Xueqin Bai, Shiwei Zhang, Yiming Cheng, Andan Qian, Shuangli Chen, Ronghui Zhou, Meihao Wang · 2025 · Academic Radiology
  82. Role of the iNOS isoform in the cardiovascular dysfunctions of male rats with 6-OHDA-induced Parkinsonism
    Lorena de Jager, Camila Borecki Vidigal, Blenda Hyedra de Campos, Gabriela de Souza Reginato, Lorena Maria Fernandes, Deborah Ariza, Carolina M. Higashi, Mariana Marques Bertozzi, Fernanda Soares Rasquel de Oliveira, Waldiceu Aparecido Verri Jr et al. · 2023 · Nitric Oxide
  83. Evaluation of Neurobehavioral and Biochemical Parameters of Poly- Herbal Formulation on MPTP-Intoxicated Mice for the Treatment of PD
    Amit Kishor Srivastava, Arif Naseer, Amresh Gupta · 2019 · Current Bioactive Compounds
  84. LRRK2; Communicative Role in the Treatment of Parkinson’s Disease and Ulcerative Colitis Overlapping
    Naser‐Aldin Lashgari, Nazanin Momeni Roudsari, Amirhossein Niknejad, Hedieh Sadat Shamsnia, Maryam Shayan, Leila Mohaghegh Shalmani, Saeideh Momtaz, Nima Rezaei, Amir Hossein Abdolghaffari · 2024 · CNS & Neurological Disorders - Drug Targets
  85. Rebalance of mitophagy by inhibiting LRRK2 improves colon alterations in an MPTP in vivo model
    Alessia Filippone, Deborah Mannino, Laura Cucinotta, Fabrizio Calapai, Lelio Crupi, Irene Paterniti, Emanuela Esposito · 2024 · iScience
  86. Role of Inflammation in Neurodegenerative Diseases
    Stanley H. Appel, David R. Beers, Weihua Zhao · 2014 · Elsevier eBooks
  87. Therapeutic strategies for Parkinson's disease based on data derived from genetic research
    Olaf Rieß, Daniela Berg, Rejko Krüger, Jörg Bernhard Schulz · 2003 · Journal of Neurology
  88. Increased extracellular glutamate evoked by 1-Methyl-4-phenylpyridinium (MPP+) in the rat striatum is not essential for dopaminergic neurotoxicity and is not derived from released glutathione
    Steven B. Foster, Haiwang Tang, Kenneth E. Miller, Glenn Dryhurst · 2005 · Neurotoxicity Research
  89. Stem-leaf saponins of Panax notoginseng attenuate experimental Parkinson's disease progression in mice by inhibiting microglia-mediated neuroinflammation via P2Y2R/PI3K/AKT/NFκB signaling pathway
    Hui Wu, Chenyang Ni, Yu Zhang, Yingying Song, Longchan Liu, Fei Huang, Hailian Shi, Zhengtao Wang, Xiaojun Wu · 2025 · Chinese Journal of Natural Medicines
  90. Neuro-protective effects of Ligustri Fructus by suppression of oxidative stress in mouse model of Parkinson’s disease
    Minsook Ye, Min Hwan Kim, Hyunsu Bae · 2016 · Oriental Pharmacy and Experimental Medicine
  91. Preventive effect of a garlic compound on astrocyte-mediated neuroinflammation in Parkinson's disease
    Jaeheon Seol, Jaehoon Kim, Sung Min Moon, Duwon Jung, Changyu Kang, Ki Wung Chung, Young‐Suk Jung, Young-Hwa Chung, Yunjin Jung, Hae Young Chung et al. · 2025 · Neuropharmacology
  92. GDNF: a Key Player in Neuron-Glia Crosstalk and Survival of Nigrostriatal Dopaminergic Neurons
    Emı́lia P. Duarte, Ana Saavedra, Graça Baltazar · 2007 · Springer eBooks
  93. Melatonin in Parkinson’s Disease and Its Therapeutic Potential
    Venkataramanujam Srinivasan, Uddanapalli Sreeramulu Srinivasan, Charanjit Kaur, Rahimah Zakaria, Zahiruddin Othman, Edward C. Lauterbach, Darı́o Acuña-Castroviejo · 2013 · Springer eBooks
  94. Neuroinflammation and Parkinson’s Disease
    Francisco Ros‐Bernal, J. E. Yuste, Ernesto Tarragón, V. Ortiz, A. Gómez, C. M. Ros, Emiliano Fernández‐Villalba, María Trinidad Herrero · 2014 · Springer eBooks
  95. Interaction of neuronal NOS and catecholamines in regulation of expression of proteins of apoptosis by vasopressinergic hypothalamic neurons
    Elena V. Chernigovskaya, L. A. Yamova, Dmitriy N. Atochin, Paul Lee Huang, Margarita V. Glazova · 2011 · Journal of Evolutionary Biochemistry and Physiology
  96. SNc Neuron Detection Method Based on Deep Learning for Efficacy Evaluation of Anti-PD Drugs
    Shuxin Zhao, Kaijie Wu, Chaochen Gu, Xiaoping Pu, Xinping Guan · 2018 · Proceedings of the ... American Control Conference/Proceedings of the American Control Conference
  97. Direct Differentiation of Adult Ocular Progenitors into Striatal Dopaminergic Neurons
    Iqbal Ahmad, Xing Zhao, Sowmya Parameswaran, Christopher J. Destache, Jorge F. Rodriguez‐Sierra, Wallace B. Thoreson, Hiba Ahmad, John Sorrentino, Sudha Balasubramanian · 2015 · International Journal of Stem Cells
  98. Parkinson's disease
    Juan Segura‐Aguilar · 2021 · Elsevier eBooks
  99. Comparative pharmacophore modeling and QSAR studies for structural requirements of some substituted 2-aminopyridines derivatives as inhibitors nitric oxide synthases
    Mukesh Chandra Sharma · 2014 · Interdisciplinary Sciences Computational Life Sciences
  100. Parkinson's Disease and Amyotrophic Lateral Sclerosis
    Rodney Lee Mosley, Ashley D. Reynolds, David K. Stone, Howard Eliot Gendelman · 2008 · Springer eBooks